buformin has been researched along with Oliguria in 1 studies
Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
buformin : A member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect.
Oliguria: Decreased URINE output that is below the normal range. Oliguria can be defined as urine output of less than or equal to 0.5 or 1 ml/kg/hr depending on the age.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Althoff, PH | 1 |
| Fassbinder, W | 1 |
| Neubauer, M | 1 |
| Koch, KM | 1 |
| Schöffling, K | 1 |
1 other study available for buformin and Oliguria
| Article | Year |
|---|---|
[Haemodialysis in the treatment of biguanide-induced lactate acidosis (author's transl)].
Topics: Acidosis; Acute Kidney Injury; Adult; Aged; Anuria; Biguanides; Buformin; Diabetes Mellitus; Female; | 1978 |